In order to test whether components of Omnia inhibit cancer cells proliferation, we treated MCF-7 cells (cell line derived from human breast cancer) with albumin conjugated Omnia. Albumin is necessary as a transporter of oleic acid (under in vitro conditions). The assay used in the experiment is colorimetric cell proliferation assay, where absorbance at a specific wavelength is proportional to cells viability.
Oleic acid, one of Omnia Drops active components, exhibits ability to inhibit growth of various cancer cell lines.
Li S, Zhou T, Li C, Dai Z, Che D, et al. (2014) High Metastaticgastric and Breast Cancer Cells Consume Oleic Acid in an AMPK Dependent Manner. PLoSONE 9(5): e97330. doi:10.1371/journal.pone.0097330
Fig. 1: Breast cancer cells viability after treatment with albumin conjugated oleic acid. After 72h incubation with 2mM albumin-conjugated Omnia cell viability was reduced to ≈ 54.5 % with respect to control.